Question:
21 CFR part 211 of USFDA describes :
21 CFR part 211 of USFDA describes :
Updated On: Feb 16, 2026
- Current good clinical practice
- Current good packaging practice
- Current good manufacturing practice
- Current good laboratory practice
Hide Solution
Verified By Collegedunia
The Correct Option is C
Solution and Explanation
The correct option is (C) : Current good manufacturing practice
Was this answer helpful?
0
0
Top Questions on Standard institutions and regulatory authorities
- The term of a patent granted under Indian Patent’s Act is:
- GPAT - 2024
- Pharmaceutical Jurisprudence
- Standard institutions and regulatory authorities
- Who has the power to fix the ceiling price of scheduled formulations:
- GPAT - 2024
- Pharmaceutical Jurisprudence
- Standard institutions and regulatory authorities
- Who has the power to fix the ceiling price of scheduled formulations:
- GPAT - 2024
- Pharmaceutical Jurisprudence
- Standard institutions and regulatory authorities
- The term of a patent granted under the Indian Patent Act is:
- GPAT - 2024
- Pharmaceutical Jurisprudence
- Standard institutions and regulatory authorities
- Ideally BA studies should be carried on ______ volunteers.
- GPAT - 2023
- Pharmaceutical Management
- Standard institutions and regulatory authorities
View More Questions
Questions Asked in GPAT exam
- Neuroleptics mediated parkinsonism is alleviated by
- GPAT - 2026
- Pharmacology of central nervous System
- Which of the following phenothiazine neuroleptic is a piperidine derivative?
- GPAT - 2026
- Pharmacology of central nervous System
- Isoxsuprine is used to treat
- GPAT - 2026
- Pharmacology of cardiovascular system
- Which of the following drugs is both $\alpha$ and $\beta$ blocker?
- GPAT - 2026
- Pharmacology of central nervous System
- Which of the following is not true for Eddy diffusion in chromatography?
- GPAT - 2026
- Chromatography and Its Principles
View More Questions